Search for: "Fields v. Eli Lilly & Company" Results 41 - 56 of 56
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Feb 2012, 5:01 pm by Lawrence Higgins
Eli Lilly's profit dropped 27% because of Zyprexa going generic. [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution –… [read post]
11 Apr 2017, 3:01 pm
  Collective and collective activities are at the center of this field. [read post]
26 May 2015, 7:42 am
  SJS/TEN is somewhat analogous in our sandbox to mesothelioma in asbestos cases, since plaintiffs often work backwards from the diagnosis to look for some drug company to sue. [read post]
19 Feb 2011, 3:32 pm
Katz sued a crop of companies over his call processing patent portfolio in a variety of venues. [read post]
11 Dec 2018, 5:50 am
 First panel discussion: Pros and Cons of Different Patent Litigation Systems in Europe The first panel was composed of Ivan Burnside (Eli Lilly), George Moore (Mylan) and Clemens Heusch (Nokia) giving their personal in-house counsel perspectives on different patent litigation systems based on their experience with parallel cases in many European jurisdictions.One of the key points to emerge from this discussion was that judges must be educated by appropriate experts in the… [read post]
21 Jan 2007, 5:42 pm
For those of us who believe patent law is an important and worthy field of law, we ought to be grateful for the attention. [read post]
22 Feb 2008, 6:00 pm
: (GenericsWeb), EU: Pharmaceutical sector enquiry regarding possible misuse of IP rights: (GenericsWeb), India: Indian government seeks to be a leader in deep sea bed mining to provide competitive edge for pharmaceutical companies in the development of new drugs: (Spicy IP),India : Medical Devices Regulation Bill formulated: (Spicy IP),India : Pharma gets bigger - Novo Nordisk and Merck & Co expansion plans: (Spicy IP),India : US patent reform and the Indian generics market:… [read post]
16 Aug 2007, 7:20 am
June 25, 2007), in which the court leveled the playing field. [read post]
31 Jul 2011, 9:28 pm
The court first found that Myriad had engaged in sufficient "affirmative acts" based on the company's assertion of its "right to preclude others... [read post]
29 Jan 2024, 4:35 pm companies/ Rhinos cont'd. [read post]